$2.36T
Total marketcap
$90.63B
Total volume
BTC 51.07%     ETH 15.55%
Dominance

Biotage AB (publ) BITGF Stock

16.87 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
1.35B USD
LOW - HIGH [24H]
16.87 - 16.87 USD
VOLUME [24H]
300 USD
{{ volume }}
P/E Ratio
54.41
Earnings per share
0.31 USD

Biotage AB (publ) Price Chart

Biotage AB (publ) BITGF Financial and Trading Overview

Biotage AB (publ) stock price 16.87 USD
Previous Close 12 USD
Open 12 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 12 - 12 USD
52 Week Range 12 - 21 USD
Volume 1 USD
Avg. Volume 5 USD
Market Cap 960.38M USD
Beta (5Y Monthly) 0.724521
PE Ratio (TTM) 36.363636
EPS (TTM) 0.31 USD
Forward Dividend & Yield 0.16 (1.29%)
Ex-Dividend Date April 28, 2023
1y Target Est N/A

BITGF Valuation Measures

Enterprise Value 791.81M USD
Trailing P/E 36.363636
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Biotage AB (publ) Stock Price History

Beta (5Y Monthly) 0.724521
52-Week Change -29.41%
S&P500 52-Week Change 20.43%
52 Week High 21 USD
52 Week Low 12 USD
50-Day Moving Average 12 USD
200-Day Moving Average 14.7 USD

BITGF Share Statistics

Avg. Volume (3 month) 5 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 66.71M
Float 65.67M
Short Ratio N/A
% Held by Insiders 0.58%
% Held by Institutions 64.88%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0.4294
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 15.57%
Operating Margin (ttm) 0%
Gross Margin 60.15%
EBITDA Margin 21.48%

Management Effectiveness

Return on Assets (ttm) 7.92%
Return on Equity (ttm) 15.27%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) -6.50%
Gross Profit (ttm) 948M USD
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) 0.33
Quarterly Earnings Growth (yoy) -39.39%

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 13.63 USD
Current Ratio (mrq) 2.743
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Biotage AB (publ)

Country United States
State N/A
City Uppsala
Address Box 8
ZIP 751 03
Phone 46 18 56 59 00
Website https://www.biotage.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 516

Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic, environmental protection, food safety, and agriculture, as well as clinical, forensic, and academic laboratories. It operates in 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Q&A For Biotage AB (publ) Stock

What is a current BITGF stock price?

Biotage AB (publ) BITGF stock price today per share is 16.87 USD.

How to purchase Biotage AB (publ) stock?

You can buy BITGF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Biotage AB (publ)?

The stock symbol or ticker of Biotage AB (publ) is BITGF.

Which industry does the Biotage AB (publ) company belong to?

The Biotage AB (publ) industry is Medical Instruments & Supplies.

How many shares does Biotage AB (publ) have in circulation?

The max supply of Biotage AB (publ) shares is 80.01M.

What is Biotage AB (publ) Price to Earnings Ratio (PE Ratio)?

Biotage AB (publ) PE Ratio is 54.41935700 now.

What was Biotage AB (publ) earnings per share over the trailing 12 months (TTM)?

Biotage AB (publ) EPS is 0.31 USD over the trailing 12 months.

Which sector does the Biotage AB (publ) company belong to?

The Biotage AB (publ) sector is Healthcare.